Jodie Pope Morrison
CIK: 0001618247
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Oct 6, 2026QTTB
Q32 Bio Inc.
Sale(S)Direct3.2K shares at avg. $8.32$27K - Aug 25, 2026QTTB
Q32 Bio Inc.
Sale(S)Direct9.8K shares at avg. $16.56$163K - Jul 16, 2026QTTB
Q32 Bio Inc.
Award(A)Direct132K shares- - Feb 25, 2026QTTB
Q32 Bio Inc.
Sale(S)Direct9.9K shares at avg. $4.51$45K - Feb 24, 2026QTTB
Q32 Bio Inc.
Award(A)Direct132K shares- - Dec 2, 2025QTTB
Q32 Bio Inc.
Sale(S)Direct22.5K shares at avg. $3.46$78K - Aug 26, 2025QTTB
Q32 Bio Inc.
Sale(S)Direct10.5K shares at avg. $1.80$19K - Jul 25, 2025VERV
Verve Therapeutics, Inc.
Disposition(D)DirectStock Option (right to buy)
42.2K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
Disposition(D)DirectStock Option (right to buy)
267.5K shares- - Jun 5, 2025VERV
Verve Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
42.2K shares- - Feb 24, 2025QTTB
Q32 Bio Inc.
Disposition(D)DirectStock Option (Right to Buy)
394.4K shares- - Feb 24, 2025QTTB
Q32 Bio Inc.
Award(A)Direct132K shares- - Feb 24, 2025QTTB
Q32 Bio Inc.
Disposition(D)DirectStock Option (Right to Buy)
152.7K shares- - Feb 24, 2025QTTB
Q32 Bio Inc.
Disposition(D)DirectStock Option (Right to Buy)
152.7K shares- - Feb 24, 2025QTTB
Q32 Bio Inc.
Disposition(D)DirectStock Option (Right to Buy)
16.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 6, 2026 |  QTTB Q32 Bio Inc. | Sale(S) | 3,221 | $8.32 | $26,798 | Direct |
| Aug 25, 2026 | QTTB Q32 Bio Inc. | Sale(S) | 9,845 | $16.56 | $163,033 | Direct |
| Jul 16, 2026 | QTTB Q32 Bio Inc. | Award(A) | 132,000 | - | $0 | Direct |
| Feb 25, 2026 | QTTB Q32 Bio Inc. | Sale(S) | 9,896 | $4.51 | $44,675 | Direct |
| Feb 24, 2026 | QTTB Q32 Bio Inc. | Award(A) | 132,000 | - | $0 | Direct |
| Dec 2, 2025 | QTTB Q32 Bio Inc. | Sale(S) | 22,506 | $3.46 | $77,871 | Direct |
| Aug 26, 2025 | QTTB Q32 Bio Inc. | Sale(S) | 10,494 | $1.80 | $18,900 | Direct |
| Jul 25, 2025 |  VERV Verve Therapeutics, Inc. | Disposition(D) Stock Option (right to buy) | 42,200 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition(D) Stock Option (right to buy) | 267,541 | - | - | Direct |
| Jun 5, 2025 | VERV Verve Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 42,200 | - | - | Direct |
| Feb 24, 2025 | QTTB Q32 Bio Inc. | Disposition(D) Stock Option (Right to Buy) | 394,445 | - | - | Direct |
| Feb 24, 2025 | QTTB Q32 Bio Inc. | Award(A) | 132,000 | - | - | Direct |
| Feb 24, 2025 | QTTB Q32 Bio Inc. | Disposition(D) Stock Option (Right to Buy) | 152,700 | - | - | Direct |
| Feb 24, 2025 | QTTB Q32 Bio Inc. | Disposition(D) Stock Option (Right to Buy) | 152,700 | - | - | Direct |
| Feb 24, 2025 | QTTB Q32 Bio Inc. | Disposition(D) Stock Option (Right to Buy) | 16,901 | - | - | Direct |
1-15 of 15 transactions
About Morrison Jodie Pope
Morrison Jodie Pope (SEC CIK 0001618247) files insider reports with the SEC as CEO of Q32 Bio Inc. (QTTB) and Director of Verve Therapeutics, Inc. (VERV).
Signal8 holds 10 ownership filings by Morrison Jodie Pope, all Form 4s, filed between Feb 26, 2025 and Oct 14, 2026. Those filings report 15 transactions, from Feb 24, 2025 to Oct 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Morrison Jodie Pope's filings is in WALTHAM, MA.
Recent filings by Morrison Jodie Pope
- Oct 6, 2026: Open-market sale of QTTB shares (Form 4, code S).
- Aug 25, 2026: Open-market sale of QTTB shares (Form 4, code S).
- Jul 16, 2026: Grant or award of QTTB shares (Form 4, code A).
- Feb 25, 2026: Open-market sale of QTTB shares (Form 4, code S).
- Feb 24, 2026: Grant or award of QTTB shares (Form 4, code A).
Other insiders filing for Q32 Bio Inc. (QTTB)
- Violette Shelia M., Chief Scientific Officer
- Kalowski Lee, CFO and President
- TZIANABOS ARTHUR, Director
- Lundberg Sven Ante, Director
- LAPORTE KATHLEEN, Director
- Iwicki Mark T, Director